| Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells IY Kim, HJ Ahn, DJ Zelner, JW Shaw, JA Sensibar, JH Kim, M Kato, C Lee Cancer research 56 (1), 44-48, 1996 | 262 | 1996 |
| Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy SF Shariat, M Shalev, A Menesses-Diaz, IY Kim, MW Kattan, TM Wheeler, ... Journal of Clinical Oncology 19 (11), 2856-2864, 2001 | 259 | 2001 |
| Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone C Lee, DM Sutkowski, JA Sensibar, D Zelner, I Kim, I Amsel, N Shaw, ... Endocrinology 136 (2), 796-803, 1995 | 249 | 1995 |
| Expression of estrogen receptors‐α and‐β in bladder cancer cell lines and human bladder tumor tissue SS Shen, CL Smith, JT Hsieh, J Yu, IY Kim, W Jian, G Sonpavde, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 245 | 2006 |
| Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. IY Kim, HJ Ahn, DJ Zelner, JW Shaw, S Lang, M Kato, MG Oefelein, ... Clinical cancer research: an official journal of the American Association …, 1996 | 232 | 1996 |
| Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer SJ Yun, P Jeong, WT Kim, TH Kim, YS Lee, PH Song, YH Choi, IY Kim, ... International journal of oncology 41 (5), 1871-1878, 2012 | 175 | 2012 |
| Expression of bone morphogenetic protein receptors type-IA,-IB, and-II correlates with tumor grade in human prostate cancer tissues IY Kim, DH Lee, HJ Ahn, H Tokunaga, W Song, LM Devereaux, D Jin, ... Cancer research 60 (11), 2840-2844, 2000 | 164 | 2000 |
| Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. IY Kim, HJ Ahn, S Lang, MG Oefelein, R Oyasu, JM Kozlowski, C Lee Clinical cancer research: an official journal of the American Association …, 1998 | 156 | 1998 |
| Diagnosis of bladder cancer and prediction of survival by urinary metabolomics X Jin, SJ Yun, P Jeong, IY Kim, WJ Kim, S Park Oncotarget 5 (6), 1635, 2014 | 153 | 2014 |
| Transforming growth factor-β: biology and clinical relevance I YiKim, MM Kim, SJ Kim BMB Reports 38 (1), 1-8, 2005 | 144 | 2005 |
| Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines IY Kim, BC Kim, DH Seong, DK Lee, JM Seo, YJ Hong, HT Kim, ... Cancer research 62 (18), 5365-5369, 2002 | 140 | 2002 |
| The human papilloma virus E7 oncoprotein inhibits transforming growth factor-β signaling by blocking binding of the Smad complex to its target sequence DK Lee, BC Kim, IY Kim, E Cho, DJ Satterwhite, SJ Kim Journal of Biological Chemistry 277 (41), 38557-38564, 2002 | 138 | 2002 |
| Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma SF Shariat, JH Kim, B Andrews, MW Kattan, TM Wheeler, IY Kim, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 130 | 2001 |
| HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array‐based DNA methylation and expression … YJ Kim, HY Yoon, JS Kim, HW Kang, BD Min, SK Kim, YS Ha, IY Kim, ... International journal of cancer 133 (5), 1135-1142, 2013 | 114 | 2013 |
| Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells IY Kim, DH Lee, DK Lee, HJ Ahn, MM Kim, SJ Kim, RA Morton Oncogene 23 (46), 7651-7659, 2004 | 97 | 2004 |
| Effect of bone morphogenetic protein‐6 on macrophages JH Hong, GT Lee, JH Lee, SJ Kwon, SH Park, SJ Kim, IY Kim Immunology 128 (1pt2), e442-e450, 2009 | 93 | 2009 |
| Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression. IY Kim, HJ Ahn, DJ Zelner, L Park, JA Sensibar, C Lee Molecular endocrinology 10 (1), 107-115, 1996 | 93 | 1996 |
| Functional and oncologic outcomes comparing interfascial and intrafascial nerve sparing in robot-assisted laparoscopic radical prostatectomies L Potdevin, M Ercolani, J Jeong, IY Kim Journal of endourology 23 (9), 1479-1484, 2009 | 89 | 2009 |
| Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP IY Kim, JH Kim, DJ Zelner, HJ Ahn, JA Sensibar, C Lee Endocrinology 137 (3), 991-999, 1996 | 89 | 1996 |
| Adapting urology residency training in the COVID-19 era YS Kwon, AL Tabakin, HV Patel, JR Backstrand, TL Jang, IY Kim, ... Urology 141, 15-19, 2020 | 88 | 2020 |
